2017
Journal Article
Title

BCX7353, a once-daily oral kallikrein inhibitor, is effective and safe in the prophylaxis of acute attacks in patients with hereditary angioedema: Attack-level analysis of the APeX-1 study

Title Supplement
Abstract
Author(s)
Aygören, E.
Bygum, A.
Steiner, U.
Magerl, M.
Panovska, V.G.
Farkas, H.
Huissoon, A.
Graff, J.
Lleonart, R.
Rae, W.
Aberer, W.
Longhurst, H.
Smith, W.
Zanichelli, A.
Cancian, M.
Guilarte, M.
Triggiani, M.
Gompels, M.
Fang, L.
Cornpropst, M.
Clemons, D.
Collis, P.
Dobo, S.
Sheridan, W.P.
Maurer, M.
Cicardi, M.
Journal
Conference
Language
English